Clinical Trials Browser

Phase 4 × Docetaxel × Thoracic × Clear all

NCT03799601 2019-01-10

ALTER-L013

Phase 4 Unknown

NSCLC

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00883675 2013-12-18

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Phase 4 Completed

133 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Terminated

14 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT01442909 2011-09-29

Pemetrexed Followed by Docetaxel or in Reverse Sequence

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00813332 2010-01-25

Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung